1. Home
  2. SPRC vs MTNB Comparison

SPRC vs MTNB Comparison

Compare SPRC & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • MTNB
  • Stock Information
  • Founded
  • SPRC 2004
  • MTNB 2013
  • Country
  • SPRC Israel
  • MTNB United States
  • Employees
  • SPRC N/A
  • MTNB N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • MTNB Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPRC Health Care
  • MTNB Health Care
  • Exchange
  • SPRC Nasdaq
  • MTNB Nasdaq
  • Market Cap
  • SPRC 3.5M
  • MTNB 3.1M
  • IPO Year
  • SPRC N/A
  • MTNB N/A
  • Fundamental
  • Price
  • SPRC $0.28
  • MTNB $0.65
  • Analyst Decision
  • SPRC
  • MTNB Hold
  • Analyst Count
  • SPRC 0
  • MTNB 1
  • Target Price
  • SPRC N/A
  • MTNB N/A
  • AVG Volume (30 Days)
  • SPRC 161.2K
  • MTNB 29.1K
  • Earning Date
  • SPRC 02-15-2025
  • MTNB 04-15-2025
  • Dividend Yield
  • SPRC N/A
  • MTNB N/A
  • EPS Growth
  • SPRC N/A
  • MTNB N/A
  • EPS
  • SPRC N/A
  • MTNB N/A
  • Revenue
  • SPRC $1,747,000.00
  • MTNB N/A
  • Revenue This Year
  • SPRC N/A
  • MTNB N/A
  • Revenue Next Year
  • SPRC N/A
  • MTNB N/A
  • P/E Ratio
  • SPRC N/A
  • MTNB N/A
  • Revenue Growth
  • SPRC N/A
  • MTNB N/A
  • 52 Week Low
  • SPRC $0.20
  • MTNB $0.48
  • 52 Week High
  • SPRC $1.79
  • MTNB $9.70
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 54.30
  • MTNB 55.90
  • Support Level
  • SPRC $0.25
  • MTNB $0.54
  • Resistance Level
  • SPRC $0.31
  • MTNB $0.60
  • Average True Range (ATR)
  • SPRC 0.02
  • MTNB 0.05
  • MACD
  • SPRC 0.01
  • MTNB 0.01
  • Stochastic Oscillator
  • SPRC 91.31
  • MTNB 100.00

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About MTNB Matinas Biopharma Holdings Inc.

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Share on Social Networks: